← Leaderboards
Joan C Gill
Medical College Of Wisconsin
$1,703,320
Attributed
$2,434,864
Total exposure
14
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $776.7K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,434,864 · 14
By mechanism
R01$1,849,019 · 2
M01$585,845 · 12
Top collaborators
- Ronald N Hines2 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Robert R Montgomery$28,575,312
- Qizhen Shi$6,437,223
- Joan Gill$1,242,561
- Mary M Horowitz$184,978,306
- David Allen Wilcox$6,145,617
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHemophilia AsCoagulation Factor ViiiFamily GeneticsComorbidityPathologic ProcessGene ExpressionDisease /Disorder Proneness /RiskInformation SystemsEpidemiologyBiomarkerBaseAlgorithmsAge-YearsCohortCooperative StudyClinical DataBody Surface AreaBlood /Lymphatic PharmacologyAnticoagulationChildhoodApolipoprotein EAge Difference
Grant awards (22)
Warfarin Pharmacogenetics in Pediatric Patients$686,402
R01 · FY2010 · HD
Warfarin Pharmacogenetics in Pediatric Patients$776,687
R01 · FY2009 · HD
UNIVERSAL DATA AMP; SERUM SPECIMEN COLLECTION FOR HEMOPHILIA$84,937
M01 · FY2006 · RR · contact PI
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA$70,782
M01 · FY2006 · RR · contact PI
THE SECOND MULTICENTER HEMOPHILIA COHORT STUDY (MHCS-II)$43,555
M01 · FY2006 · RR · contact PI
DELTA HEPATITIS AND HEPATITIS C IN HEMOPHILIA$37,965
M01 · FY2006 · RR · contact PI
GENETICS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA$1,288
M01 · FY2006 · RR · contact PI
UNIVERSAL DATA &SERUM SPECIMEN COLLECTION FOR HEMOPHILIA$68,747
M01 · FY2005 · RR
DELTA HEPATITIS AND HEPATITIS C IN HEMOPHILIA$36,063
M01 · FY2005 · RR
THE SECOND MULTICENTER HEMOPHILIA COHORT STUDY (MHCS-II)$35,739
M01 · FY2005 · RR
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA$31,556
M01 · FY2005 · RR
GENETICS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA$2,253
M01 · FY2005 · RR
Universal Data &Serum Specimen Collection for Hemophilia$85,786
M01 · FY2004 · RR
THE SECOND MULTICENTER HEMOPHILIA COHORT STUDY (MHCS-II)$37,069
M01 · FY2004 · RR
Delta hepatitis and hepatitis C in hemophilia$28,849
M01 · FY2004 · RR
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia$21,256
M01 · FY2004 · RR
GENETICS OF INHIBITOR FORMATION IN HEMOPHILIA$188,567
R01 · FY2001 · HL
GENETICS OF INHIBITOR FORMATION IN HEMOPHILIA$197,363
R01 · FY2000 · HL
PHARMACOKINETICS OF TRANSFUSED VW FACTOR &FVIII IN VW DIS.$0
M01 · FY2000 · RR
GENETICS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA$0
M01 · FY2000 · RR
GENETICS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA$0
M01 · FY2000 · RR
PHARMACOKINETICS OF TRANSFUSED VW FACTOR &FVIII IN VW DIS.$0
M01 · FY2000 · RR